Vertex Pharmaceuticals Inc (VRTX)
450.53
+0.16
(+0.04%)
USD |
NASDAQ |
Nov 22, 16:00
451.02
+0.49
(+0.11%)
After-Hours: 20:00
Vertex Pharmaceuticals Stock Buybacks (Quarterly): 391.40M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 391.40M |
June 30, 2024 | 400.80M |
March 31, 2024 | 364.70M |
December 31, 2023 | 152.70M |
September 30, 2023 | 170.20M |
June 30, 2023 | 31.40M |
March 31, 2023 | 299.40M |
December 31, 2022 | 2.10M |
September 30, 2022 | 48.00M |
June 30, 2022 | 4.40M |
March 31, 2022 | 117.50M |
December 31, 2021 | 369.90M |
September 30, 2021 | 660.80M |
June 30, 2021 | 3.60M |
March 31, 2021 | 527.00M |
December 31, 2020 | 151.59M |
September 30, 2020 | 148.54M |
June 30, 2020 | 3.08M |
March 31, 2020 | 436.19M |
December 31, 2019 | 36.05M |
September 30, 2019 | 0.104M |
June 30, 2019 | 56.01M |
March 31, 2019 | 99.84M |
December 31, 2018 | 143.00M |
September 30, 2018 | 92.00M |
Date | Value |
---|---|
June 30, 2018 | 105.03M |
March 31, 2018 | 10.00M |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
2.10M
Minimum
Dec 2022
660.80M
Maximum
Sep 2021
215.97M
Average
152.15M
Median
Stock Buybacks (Quarterly) Benchmarks
Gilead Sciences Inc | 202.00M |
Eli Lilly and Co | 446.10M |
Bristol-Myers Squibb Co | 0.00 |
Moderna Inc | -8.00M |
Pfizer Inc | -- |